Here, we provide evidence that TNFα is downregulated in HNSCC cells with ATAD3A loss, which implicates ATAD3A-mediated ERK1/2 signaling from the MOM towards nuclear targets. The gene discussed is ATAD3A; the disease is head and neck squamous cell carcinoma.